These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26803420)

  • 1. Trends in Complications and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Experience From the PARTNER Continued Access Registry.
    Beohar N; Kirtane AJ; Blackstone E; Waksman R; Holmes D; Minha S; Alli O; Suri RM; Svensson LG; Leon M; Kodali S
    JACC Cardiovasc Interv; 2016 Feb; 9(4):355-363. PubMed ID: 26803420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
    Fearon WF; Kodali S; Doshi D; Fischbein MP; Yeung AC; Tuzcu EM; Rihal CS; Babaliaros V; Zajarias A; Herrmann HC; Brown DL; Mack M; Teirstein PS; Whisenant BK; Makkar R; Kapadia S; Leon MB;
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1245-51. PubMed ID: 25459036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).
    Hahn RT; Pibarot P; Webb J; Rodes-Cabau J; Herrmann HC; Williams M; Makkar R; Szeto WY; Main ML; Thourani VH; Tuzcu EM; Kapadia S; Akin J; McAndrew T; Xu K; Leon MB; Kodali SK
    JACC Cardiovasc Interv; 2014 Jul; 7(7):781-9. PubMed ID: 25060022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves).
    Paradis JM; Maniar HS; Lasala JM; Kodali S; Williams M; Lindman BR; Damiano RJ; Moon MR; Makkar RR; Thourani VH; Babaliaros V; Xu K; Ayele GM; Svensson L; Leon MB; Zajarias A
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1468-1479. PubMed ID: 26404200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: the U.K. Transcatheter Aortic Valve Implantation Registry.
    Duncan A; Ludman P; Banya W; Cunningham D; Marlee D; Davies S; Mullen M; Kovac J; Spyt T; Moat N
    JACC Cardiovasc Interv; 2015 Apr; 8(5):645-53. PubMed ID: 25946435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
    JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of transfemoral versus transapical access on mortality among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Koifman E; Magalhaes M; Kiramijyan S; Escarcega RO; Didier R; Torguson R; Ben-Dor I; Corso P; Shults C; Satler L; Pichard A; Waksman R
    Cardiovasc Revasc Med; 2016; 17(5):318-21. PubMed ID: 27394178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-Procedural Hemodynamic Status Improves the Discriminatory Value of the Aortic Regurgitation Index in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Sinning JM; Stundl A; Pingel S; Weber M; Sedaghat A; Hammerstingl C; Vasa-Nicotera M; Mellert F; Schiller W; Kovac J; Welz A; Grube E; Werner N; Nickenig G
    JACC Cardiovasc Interv; 2016 Apr; 9(7):700-11. PubMed ID: 27056309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Importance of Diastolic Dysfunction in Relation to Post Procedural Aortic Insufficiency in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Kampaktsis PN; Bang CN; Chiu Wong S; Skubas NJ; Singh H; Voudris K; Baduashvili A; Pastella K; Swaminathan RV; Kaple RK; Minutello RM; Feldman DN; Kim L; Hriljac I; Lin F; Bergman GS; Salemi A; Devereux RB
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):445-451. PubMed ID: 27218599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.
    Lefèvre T; Colombo A; Tchétché D; Latib A; Klugmann S; Fajadet J; De Marco F; Maisano F; Bruschi G; Bijuklic K; Nava S; Weissman N; Low R; Thomas M; Young C; Redwood S; Mullen M; Yap J; Grube E; Nickenig G; Sinning JM; Hauptmann KE; Friedrich I; Lauterbach M; Schmoeckel M; Davidson C; Schofer J
    JACC Cardiovasc Interv; 2016 Jan; 9(1):68-75. PubMed ID: 26762913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
    Herrmann HC; Thourani VH; Kodali SK; Makkar RR; Szeto WY; Anwaruddin S; Desai N; Lim S; Malaisrie SC; Kereiakes DJ; Ramee S; Greason KL; Kapadia S; Babaliaros V; Hahn RT; Pibarot P; Weissman NJ; Leipsic J; Whisenant BK; Webb JG; Mack MJ; Leon MB;
    Circulation; 2016 Jul; 134(2):130-40. PubMed ID: 27400898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of percutaneous paravalvular regurgitation closure after transcatheter aortic valve replacement: a multicenter experience.
    Saia F; Martinez C; Gafoor S; Singh V; Ciuca C; Hofmann I; Marrozzini C; Tan J; Webb J; Sievert H; Marzocchi A; O'Neill WW
    JACC Cardiovasc Interv; 2015 Apr; 8(5):681-8. PubMed ID: 25946440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.
    Jerez-Valero M; Urena M; Webb JG; Tamburino C; Munoz-Garcia AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Alonso Briales JH; Al Lawati H; Benitez LM; Cucalon AM; Garcia del Blanco B; Revilla A; Dumont E; Barbosa Ribeiro H; Nombela-Franco L; Bergeron S; Pibarot P; Rodés-Cabau J
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1022-32. PubMed ID: 25234675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
    Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
    Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
    JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
    Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
    J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.